Trading Options with an Edge
Select Page

IMVT

Search by
TICKER SYMBOL

Immunovant Inc

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing

4.99

-0.21

(-4.038%)

Volume:

188,719

52 week range:

3.15 - 9.54

Market Cap:

581.72M

Company Description:

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.